Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Jim Van Meerten

Is This Pharmaceutical Giant a Winning Tariff-Proof Stock to Buy for 2026?

  • Novartis (NVS) is trading at new all-time highs on Monday.
  • Shares are up nearly 50% over the past 52 weeks.
  • NVS maintains a 100% “Buy” technical opinion from Barchart.
  • Novartis has benefitted in recent days from its CEO’s comments that the company will have essentially limited tariff exposure by mid-2026. 

Today’s Featured Stock 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.